1. Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate

   • Roberto Petrioli
   • Edoardo Francini
   • Giandomenico Roviello

   Review Article 17 June 2015 Pages: 439 - 445

2. Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats

   • Yanira Gonzalez
   • Kaytee L. Pokrzywinski
   • V. Ashutosh Rao

   Original Article 25 June 2015 Pages: 447 - 459

   

3. AT-101 inhibits hedgehog pathway activity and cancer growth

   • Juan Wang
   • Yuanqiu Peng
   • Wenfu Tan

   Original Article 26 June 2015 Pages: 461 - 469

   

4. NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K–AKT cascade

   • Dipon Das
   • Shakti Ranjan Satapathy
   • Chanakya Nath Kundu

   Original Article 30 June 2015 Pages: 471 - 479

   

5. Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer

   • Yaman Suleiman
   • Amit Mahipal
   • Richard Kim

   Original Article 01 July 2015 Pages: 481 - 487

   

6. Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma

   • David Fogelman
   • Elizabeth A. Sugar
   • Luis A. Diaz Jr.

   Original Article 01 July 2015 Pages: 489 - 498

   

7. Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease

   • Yasunori Enomoto
   • Naoki Inui
   • Takafumi Suda

   Original Article 02 July 2015 Pages: 499 - 505

   

8. Integrated nonclinical and clinical risk assessment of the investigational proteasome inhibitor ixazomib on the QTc interval in cancer patients

   • Neeraj Gupta
   • Yeamin Huh
   • Karthik Venkatakrishnan

   Original Article 04 July 2015 Pages: 507 - 516

   

9. A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer

   • Yun Fan
   • Zhiyu Huang
   • Weimin Mao

   Original Article 07 July 2015 Pages: 517 - 523

   

10. In vivo pharmacokinetic and tissue distribution investigation of sustained-release cisplatin implants in the normal esophageal submucosa of 12 beagle dogs

    • Jia-Xue Yin
    • Zhi Wei
    • Zi-Qin Sun

    Original Article 17 July 2015 Pages: 525 - 536

    

11. Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612)

    • Robert A. Parise
    • Julie L. Eiseman
    • Jan H. Beumer

    Original Article 21 July 2015 Pages: 537 - 546

    

12. A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer

    • Tomohiro Nishina
    • Takeshi Kato
    • Ichinosuke Hyodo

    Original Article 22 July 2015 Pages: 547 - 553

    

13. Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives

    • Tijana Stanković
    • Balázs Dankó
    • Milica Pešić

    Original Article 22 July 2015 Pages: 555 - 565

    

14. Modeling and simulations relating overall survival to tumor growth inhibition in renal cell carcinoma patients

    • Laurent Claret
    • Francois Mercier
    • Rene Bruno

    Original Article 22 July 2015 Pages: 567 - 573

    

15. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells

    • Dan Yang
    • Jinglei Qu
    • Yunpeng Liu

    Original Article 25 July 2015 Pages: 575 - 586

    

16. Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors

    • Amita Patnaik
    • Anthony Tolcher
    • Jianguo Zhi

    Original Article 26 July 2015 Pages: 587 - 595

    

17. A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors

    • H. Henary
    • G. C. George
    • D. S. Hong

    Original Article 26 July 2015 Pages: 597 - 603

    

18. S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies

    • Satoru Iwasa
    • Kengo Nagashima
    • Yasuhide Yamada

    Original Article 29 July 2015 Pages: 605 - 614

    

19. A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer

    • Takahiro Goji
    • Tetsuo Kimura
    • Tetsuji Takayama

    Original Article 29 July 2015 Pages: 615 - 620

    

20. Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine

    • Radosław Mlak
    • Paweł Krawczyk
    • Teresa Małecka-Massalska

    Original Article Open access 29 July 2015 Pages: 621 - 629

    

21. A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors

    • Haruyasu Murakami
    • Masafumi Ikeda
    • Nobuyuki Yamamoto

    Original Article 30 July 2015 Pages: 631 - 639

    

22. Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1

    • Liu Ying
    • Yin Chunxia
    • Liu Wei

    Original Article 31 July 2015 Pages: 641 - 650

    

23. Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis

    • Jie Li
    • Rong Chen
    • Li-na Zhu

    Clinical Trial Report 21 June 2015 Pages: 651 - 655

24. RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines

    • Rui Peng
    • Hong Zhang
    • Dan-yun Wei

    Original Article Open access 21 June 2015 Pages: 657 - 657